1. Home
  2. FSI vs CRDL Comparison

FSI vs CRDL Comparison

Compare FSI & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

HOLD

Current Price

$6.86

Market Cap

86.6M

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.05

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSI
CRDL
Founded
1991
2017
Country
Canada
Canada
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.6M
97.3M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
FSI
CRDL
Price
$6.86
$1.05
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
56.4K
630.5K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
1.45%
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$38,563,427.00
N/A
Revenue This Year
$8.45
N/A
Revenue Next Year
$51.24
N/A
P/E Ratio
$49.13
N/A
Revenue Growth
0.18
N/A
52 Week Low
$3.46
$0.77
52 Week High
$11.48
$1.59

Technical Indicators

Market Signals
Indicator
FSI
CRDL
Relative Strength Index (RSI) 37.77 52.30
Support Level $6.35 $0.88
Resistance Level $7.13 $1.11
Average True Range (ATR) 0.43 0.08
MACD 0.02 0.00
Stochastic Oscillator 32.90 69.57

Price Performance

Historical Comparison
FSI
CRDL

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: